SEC Form D private-offering filing
PridCor Therapeutics, LLC
A new SEC Form D private-offering notice from Tuscaloosa, AL, a $1,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical stage biopharmaceutical company developing antiviral therapies for Long COVID and other infection associated chronic illnesses, founded by Dr. William Pridgen.
Filed 2026-02-02Filed to raise $1,000,000HQ (as filed) Tuscaloosa, ALSector Biotech ✓Stage (inferred) SeedCall status No reported sale
Source linked the Form D on EDGAR↗Website verified pridcor.com↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.